Skip to content

Neuroimaging mechanism of low field magnetic stimulation in the treatment of major depression: a 6-week, randomized, double-blind, sham stimulation controlled clinical trial

Neuroimaging mechanism of therapeutic low field magnetic stimulation in the treatment of major depression

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044283
Enrollment
Unknown
Registered
2021-03-14
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

1:LFMS

Sponsors

Beijing An Ding Hospital, Capital medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Outpatients or inpatients, aged from 18 to 60 years old (including 18 and 60 years old), male or female; 2) According to the diagnostic criteria of major depressive disorder (Mini 5.0.0) of DSM-IV, the first episode or relapse is acceptable, without psychotic symptoms; 3) The total score of 17 item Hamilton Rating Scale for depression (HAMD-17) was more than or equal to 14; 4) The cumulative use of antidepressants in the past 14 days did not exceed 7 days; 5) Right handed; 6) Informed consent was signed by the patient.

Exclusion criteria

Exclusion criteria: 1) The patients with schizophrenia, bipolar disorder, schizophrenic affective disorder or other mental disorders were diagnosed before; 2) Alcohol and drug dependence or acute poisoning within one year; 3) Pregnant or lactating women; 4) The researchers believe that the patient has a serious risk of suicide; 5) At present, some researchers with serious physical diseases think that they are not suitable for this study; 6) In recent 6 months, the patients were treated with antipsychotic long-term injection; 7) Patients with thyroid dysfunction and need treatment before enrollment; 8) Previous history of head injury or nervous system injury or recurrent headache attack; 9) One year before entering the group, they had received electrospasmodic treatment; 10) Implanting metal objects that cannot be removed, such as dentures, artery clips, pacemakers or metal fixators; 11) Refractory depression (previously treated with two or more antidepressants for 6 weeks was ineffective); 12) There are contraindications to MRI scanning.

Design outcomes

Primary

MeasureTime frame
brain function;

Countries

China

Contacts

Public ContactLe Xiao

Beijing An Ding Hospital, Capital medical university

xiaole373@163.com+86 010-58303289

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026